イミキモド
↑ Walter, Anne; Schäfer, Matthias; Cecconi, Virginia; Matter, Claudia; Urosevic-Maiwald, Mirjana; Belloni, Benedetta; Schönewolf, Nicola; Dummer, Reinhard et al. (2013). “Aldara activates TLR7-independent immune defence”. Nature Communications 4: 1560. Bibcode: 2013NatCo...4.1560W. doi:10.1038/ncomms2566. PMID 23463003.
↑ Hemmi, Hiroaki; Kaisho, Tsuneyasu; Takeuchi, Osamu; Sato, Shintaro; Sanjo, Hideki; Hoshino, Katsuaki; Horiuchi, Takao; Tomizawa, Hideyuki et al. (2002). “Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway”. Nature Immunology 3 (2): 196–200. doi:10.1038/ni758. PMID 11812998.
↑ Sauder, D.N. (2003). “Imiquimod: Modes of action”. British Journal of Dermatology 149: 5–8. doi:10.1046/j.0366-077x.2003.
↑ Drugs.com Drugs.com international listings for imiquimod Page accessed June 14, 2015
1 2 “Imiquimod topical Use During Pregnancy”. Drugs.com (2019年5月29日). 2020年7月14日閲覧。
↑ “Imiquimod Topical” (英語). MedlinePlus. National Library of Medicine. 2021年6月2日閲覧。
1 2 3 “ベセルナクリーム5% 添付文書”. www.info.pmda.go.jp. PMDA. 2021年6月20日閲覧。
↑ 'Imiquimod should be used for treatment of [superficial basal cell carcinoma] only when surgery is medically less appropriate ... .' USA Food And Drug Administration, 'FDA Approval for Imiquimod', , current at 2011-Jan-1, accessed 2012-Oct-19
↑ American Cancer Society, Guide To Cancer Drugs, (accessed 2014-Apr-28)
1 2 3 European Medicines Agency. First published Sept 14,2009, updated March 25, 2015.